Fri.Mar 05, 2021

article thumbnail

Countering payers, drugmakers say net prices declined in 2020

Bio Pharma Dive

Reports from three large pharmaceutical companies indicate increasing rebate payments and discounts to insurers more than offset the average price increases they took on their medicines.

Medicine 267
article thumbnail

The most important website metrics

World of DTC Marketing

SUMMARY: Your product website is a window between your brand and target audience. You might not be able to talk to one another, but what your audience does behind that window can tell you a lot about how they’re thinking about your brand. I really don’t care about website visitors when I examine analytics because they don’t mean that much.

Branding 155
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biotech's deal refusals led to pricey buyout by Merck

Bio Pharma Dive

Pandion rejected multiple offers by Merck to partner on or acquire the small biotech's research before accepting a $1.85 billion acquisition bid last month.

Research 195
article thumbnail

Nerivio: New Drug-Free Wearable Technology Used to Treat Migraines

XTalks

Nerivio is a new drug-free wearable technology that has treated 100,000 migraines in the US. Theranica, the company that owns Nerivio, develops advanced electroceuticals used for migraines and other pain conditions. The prescribed digital therapeutics company describes Nerivio as the first FDA-cleared and CE-marked smartphone-controlled prescription wearable device for people 12 years or older suffering from migraines. “We are at a crossroads for acute migraine treatment, where traditional

Drugs 102
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Intouch Lives to Learn … and Teach

Intouch Solutions

Summer is around the corner, and that means it's time for more learning! Read on to find out more about our free copywriting class, plus 2021 internship opportunities at Intouch. Don't miss out! The post Intouch Lives to Learn … and Teach appeared first on Intouch Solutions.

98
article thumbnail

Could personalised medicine change treatment for migraine?

pharmaphorum

The concept of personalised medicine is becoming established in cancer, with an increasing number of drugs targeting specific mutations making it to market. Alec Mian, CEO at diagnostics firm Curelator, spoke to pharmaphorum’s news editor Richard Staines about the company’s plans to apply a similar paradigm to other diseases such as migraine. . There has been noticeable progress in migraine as a disease area in the last few years, with a new class of drugs coming to market that could help preven

More Trending

article thumbnail

Health Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technology

pharmaphorum

In the latest episode of our Health Innovators series, Paul Tunnah speaks to Billy Boyle, co-founder and CEO of Owlstone Medical, one of the UK’s most promising diagnostic startups. The Cambridge, UK-based company is on a mission to save 100,000 lives and $1.5bn in healthcare costs with its breath biopsy platform for early detection of cancer. Owlstone is developing a breath-based analyser that captures Volatile Organic Compounds (VOCs) in breath non-invasively, and analyses them with high sensi

article thumbnail

A new and non-intrusive method for preventing cyber attacks on Android devices

Scienmag

Credit: Singapore Management University SMU Office of Research and Tech Transfer – Cyber attacks on mobile devices are on the rise, with over 100 million attacks reported per year since 2018. Despite this, recent security research shows that most companies have unprotected data and poor cybersecurity practices in place, thus making them vulnerable to data […].

article thumbnail

State Drug Importation Program Relabeling Requirement Says It All

Pharmacy Checkers

For the benefit of consumers, I published a longish but straightforward explanation of the state wholesale drug importation bills, laws, and programs and how they differ from personal importation. I reviewed the drug relabeling section of Florida’s Drug Importation Program submission to the U.S. Department of Health and Human Services, and it really tells a story.

Drugs 89
article thumbnail

How bone marrow regenerates after chemotherapy

Scienmag

Researchers from Osaka University identify the molecular mechanism underlying bone marrow regeneration after chemotherapy Credit: Osaka University Osaka, Japan – Chemotherapy has a damaging effect on hematopoietic stem and progenitor cells (HSPCs) in bone marrow. However, once chemotherapy ends, HSPCs regenerate, a process that has remained unknown–until now.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Modified COVID-19 vaccines can avoid ‘lengthy’ clinical studies, says MHRA

Pharma Times

UK’s regulatory authority will fast-track jabs modified to new variants

article thumbnail

New quantum theory heats up thermodynamic research

Scienmag

Credit: Beth Morris, University of Nottingham Maths PhD Researchers have developed a new quantum version of a 150-year-old thermodynamical thought experiment that could pave the way for the development of quantum heat engines. Mathematicians from the University of Nottingham have applied new quantum theory to the Gibbs paradox and demonstrated a fundamental difference in the […].

article thumbnail

ClinSpec Diagnostics reaches funding target of £3.5m

Pharma Times

University of Strathclyde spin-out is developing liquid biopsies for early cancer detection

article thumbnail

“Magic sand” might help us understand the physics of granular matter

Scienmag

Children’s toy an ideal modifier for interparticle adhesion and mechanical properties Credit: Tokyo Metropolitan University Tokyo, Japan – Researchers from Tokyo Metropolitan University have studied the properties of mixtures of silicone-coated “magic sand”, a popular kid’s toy, and normal sand. Silicone-coated sand particles were found to interact with each other only, and not with other […].

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Lilly’s tirzepatide claims head-to-head trial win against injectable semaglutide

Pharma Times

Tirzepatide demonstrated superior A1C and body weight reduction in type 2 diabetes

Trials 88
article thumbnail

New Corona test developed

Scienmag

Researchers develop a low-cost and fast method to detect a COVID-19 infection from a pool of gargle lavage samples Credit: MPI f. Evolutionary Anthropology Quantitative real-time polymerase chain reaction (qPCR) is the most widely used diagnostic method to detect RNA viruses such as SARS-CoV-2. However, it requires expensive laboratory equipment and global shortages of reagents […].

article thumbnail

The post-COVID face of pharma research and development

pharmaphorum

The acute phase of the COVID-19 pandemic not only brought delays, restrictions, and reconfigurations to pharmaceutical research & development in 2020, but also a more flexible response to some long-standing issues with the clinical trials process. . Lockdown rules and safety protocols certainly made it harder for patients to travel to trial sites, while a refocusing of clinical personnel to COVID projects slowed work that wasn’t dedicated to the novel coronavirus.

article thumbnail

Survey identifies factors in reducing clinical research coordinator turnover

Scienmag

Credit: Vanderbilt University Medical Center Strong, collaborative relationships with principal investigators are a key factor of longevity in clinical research coordinator positions — an essential, but increasingly transient job in executing treatment-advancing clinical trials, Vanderbilt University Medical Center researchers found. Danielle Buchanan, BS, clinical translational research coordinator III in the Department of Neurology, and Daniel […].

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

New patent expiration for Acadia Pharms drug NUPLAZID

Drug Patent Watch

Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from one supplier. There are nineteen…. The post New patent expiration for Acadia Pharms drug NUPLAZID appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Light in concert with force reveals how materials become harder when illuminated

Scienmag

When indented by a probe in darkness, wafers of some semiconductors are putty-like. When illuminated by light whose wavelength matches the band gap, they become hard, as electrons and holes freed by the light suppress the propagation of dislocations Credit: Atsutomo Nakamura Semiconductor materials play an indispensable role in our modern information-oriented society.

article thumbnail

New patent expiration for Evofem Inc drug PHEXXI

Drug Patent Watch

Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent expiration for Evofem Inc drug PHEXXI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Decreases in exercise closely linked with higher rates of depression during the pandemic

Scienmag

Study of college students showed that the disruption to physical activity is a leading risk factor for depression during this period Credit: Pheelings Media Exercise has long-been recommended as a cognitive-behavioral therapy for patients of depression, yet new evidence from the University of California of San Diego suggests that the COVID-19 pandemic changed the nature […].

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

New patent for Baxter Hlthcare drug NOURESS

Drug Patent Watch

Annual Drug Patent Expirations for NOURESS Nouress is a drug marketed by Baxter Hlthcare Corp and is included in one NDA. There are six patents protecting this drug. Drug patent…. The post New patent for Baxter Hlthcare drug NOURESS appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Canadian scientists and Swiss surgeons discover the cause of excess post-surgical scarring

Scienmag

The finding could improve recovery from abdominal and pelvic surgery Credit: Supplied by Kubes’ Lab, Snyder Institute for Chronic Disease, Cumming School of Medicine, University of Calgary The body is amazing at healing itself. However, sometimes it can overdo it. Excess scarring after abdominal and pelvic surgery within the peritoneal cavity can lead to serious […].

article thumbnail

Merck Begins Tender Offer to Acquire Pandion Therapeutics

The Pharma Data

Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Pandion Therapeutics, Inc. (Nasdaq: PAND). On Feb. 25, 2021, Merck announced its intent to acquire Pandion. Upon the successful closing of the tender offer, stockholders of Pandion will receive $60 in cash for each share of Pandion common stock validly tendered and not validly withdrawn in the offer, without int

article thumbnail

The gut mycobiome influences the metabolism of processed foods

Scienmag

New research in mice points to a significant role for fungi to shape metabolism, including fat deposition, and metabolic hormones. Credit: UAB BIRMINGHAM, Ala. – Studies of the microbiome in the human gut focus mainly on bacteria. Other microbes that are also present in the gut — viruses, protists, archaea and fungi — have been […].

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Roche’s Actemra/RoActemra becomes the first biologic therapy approved by the FDA for slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease, a rare, debilitating condition

The Pharma Data

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Actemra ® /RoActemra ® (tocilizumab) subcutaneous injection for slowing the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD), a debilitating condition with limited treatment options.

article thumbnail

Tracking proteins in the heart of cells

Scienmag

For the first time, a UNIGE team has been able to follow precisely the path taken by a protein within the cell, paving the way for the study of the transport and distribution network of vital elements necessary for its survival. Credit: © UNIGE In order to stay alive, the cell must provide its various […].

Protein 82
article thumbnail

Novartis signs initial agreement with CureVac to manufacture COVID-19 vaccine candidate

The Pharma Data

Novartis announced today that it has signed an initial agreement to manufacture the mRNA and bulk drug product for the COVID-19 vaccine candidate CVnCoV from CureVac to aid in the fight against the COVID-19 pandemic. Preparations for the start of production, technology transfer and test runs are already underway. Following final agreement, Novartis plans to start production in the second quarter of 2021.

article thumbnail

Charting our changing cities

Scienmag

Left (top-bottom): SMU Associate Professor of Science, Technology and Society Winston Chow; SMU Associate Professor Humanities Orlando Woods. SMU Office of Research & Tech Transfer – For most of human history, populations across the world lived in low-density, rural settings. Over the past few centuries, however, this changed dramatically with the trend of urbanisation.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.